XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
8. Stock Option Plans and Agreements (Details 1)
3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Number of Options, Outstanding (in shares) at December 31, 2016 | shares 8,583,000
Number of Options, Options granted (in shares) | shares 150,000
Number of Options, Options expired (in shares) | shares (22,500)
Number of Options, Options forfeited (in shares) | shares (12,500)
Number of Options, Outstanding (in shares) at March 31, 2017 | shares 8,698,000
Number of option, Vested or expected to vest at March 31, 2017 | shares 6,310,000
Number of Options, Exercisable (in shares) at March 31, 2017 | shares 6,110,000
Weighted Average Exercise Price, Outstanding (in dollars per share) at December 31, 2016 | $ / shares $ 0.12
Weighted Average Exercise Price, Options granted (in dollars per share) | $ / shares 0.045
Weighted Average Exercise Price, Options expired (in dollars per share) | $ / shares 0.26
Weighted Average Exercise Price, Options forfeited (in dollars per share) | $ / shares 0.04
Weighted Average Exercise Price, Outstanding (in dollars per share) at March 31, 2017 | $ / shares 0.12
Weighted Average Exercise Price, Vested or expected to vest at March 31, 2017 | $ / shares 0.09
Weighted Average Exercise Price, Exercisable (in dollars per share) at March 31, 2017 | $ / shares $ 0.09
Weighted-Average Remaining Contractual Term, Outstanding at March 31, 2017 4 years
Weighted-Average Remaining Contractual Term, Vested or expected to vest at March 31, 2017 5 years 1 month 6 days
Weighted-Average Remaining Contractual Term, Exercisable at March 31, 2017 5 years 1 month 6 days
Aggregate Intrinsic Value, Outstanding (in dollars) at March 31, 2017 | $ $ 2,700
Aggregate Intrinsic Value, Vested or expected to vest at March 31, 2017 | $ 2,700
Aggregate Intrinsic Value, Exercisable (in dollars) at March 31, 2017 | $ $ 2,700